Carriedelle Wilson Fusco, FNP-BC

Article

Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?

Author:

Matthew Roe, MD

Courtenay Gilmore Wilson, PharmD, BCPS, BCACP, CDE, CPP

Carriedelle Wilson Fusco, FNP-BC

Stephen Hulkower, MD

Sue Stigleman, MLS

EVIDENCE-BASED ANSWER: Yes. Monthly extended-release injectable naltrexone (XR-NTX) treats opioid use disorder as effectively as daily sublingual...

• Read More